VFA
REGN icon

Voya Financial Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Voya Financial Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-551
Closed -$259K – 520
2021
Q1 		$259K Buy
551
+100
+22% +$48.7K 0.01% 575
2020
Q4 		$216K Sell
451
-44
-9% -$23.8K 0.01% 594
2020
Q3 		$284K Sell
495
-98
-17% -$59.4K 0.01% 484
2020
Q2 		$362K Sell
593
-251
-30% -$142K 0.02% 439
2020
Q1 		$399K Buy
+844
New +$348K 0.02% 386

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Voya Financial Advisors's REGN Position: Q2 2021 in Review

Voya Financial Advisors sold out of Regeneron Pharmaceuticals (REGN) in Q2 2021, closing a stake of 551 shares — an estimated $259K sold.

Voya Financial Advisors first reported a position in REGN in Q1 2020 and held it in 5 quarters. The position peaked at $399K in Q1 2020. 971 funds tracked by Wall St. Rank hold REGN as of Q2 2021.

  • Voya Financial Advisors reported no remaining Regeneron Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Voya Financial Advisors sold 551 Regeneron Pharmaceuticals shares in Q2 2021, an estimated $259K.
  • Voya Financial Advisors first reported a position in Regeneron Pharmaceuticals in Q1 2020 and held it in 5 quarters.
  • Voya Financial Advisors's Regeneron Pharmaceuticals position peaked at $399K in Q1 2020.
  • 971 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2021.

Based on Voya Financial Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.